{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:29:26Z","timestamp":1793399366606,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98505-y","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:13:01Z","timestamp":1745431981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cytokine profiles dynamics in COVID-19 patients: a longitudinal analysis of disease severity and outcomes"],"prefix":"10.1038","volume":"15","author":[{"given":"Sara","family":"Ghaffarpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Ghazanfari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sussan Kaboudanian","family":"Ardestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Naghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Vaez Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Mohammad Mohseni","family":"Majd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Rajabnia","family":"Chenary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrollah","family":"Mostafazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Iranparast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein Ali","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"10223","key":"98505_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223), 497\u2013506. https:\/\/doi.org\/10.1016\/s0140-6736(20)30183-5 (2020).","journal-title":"Lancet"},{"issue":"4","key":"98505_CR2","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.21037\/apm-20-887","volume":"9","author":"H Yue","year":"2020","unstructured":"Yue, H. et al. Clinical characteristics of coronavirus disease 2019 in Gansu Province, China. Ann. Palliat. Med. 9(4), 1404\u20131412. https:\/\/doi.org\/10.21037\/apm-20-887 (2020).","journal-title":"Ann. Palliat. Med."},{"issue":"13","key":"98505_CR3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. Jama 323(13), 1239\u20131242. https:\/\/doi.org\/10.1001\/jama.2020.2648 (2020).","journal-title":"Jama"},{"issue":"13","key":"98505_CR4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","volume":"69","author":"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus","year":"2020","unstructured":"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus. Disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal. Wkly. Rep. 69(13), 382\u2013386. https:\/\/doi.org\/10.15585\/mmwr.mm6913e2 (2020).","journal-title":"MMWR Morb Mortal. Wkly. Rep."},{"issue":"5","key":"98505_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar, R. & Perlman, S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 39(5), 529\u2013539. https:\/\/doi.org\/10.1007\/s00281-017-0629-x (2017).","journal-title":"Semin Immunopathol."},{"issue":"10229","key":"98505_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/s0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229), 1033\u20131034. https:\/\/doi.org\/10.1016\/s0140-6736(20)30628-0 (2020).","journal-title":"Lancet"},{"issue":"7","key":"98505_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 180(7), 934\u2013943. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994 (2020).","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"98505_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/s2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 8(5), 475\u2013481. https:\/\/doi.org\/10.1016\/s2213-2600(20)30079-5 (2020).","journal-title":"Lancet Respir Med."},{"issue":"6504","key":"98505_CR9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369(6504), 718\u2013724. https:\/\/doi.org\/10.1126\/science.abc6027 (2020).","journal-title":"Science"},{"issue":"7821","key":"98505_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584(7821), 463\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2588-y (2020).","journal-title":"Nature"},{"issue":"6508","key":"98505_CR11","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369(6508), 1210\u20131220. https:\/\/doi.org\/10.1126\/science.abc6261 (2020).","journal-title":"Science"},{"issue":"22","key":"98505_CR12","doi-asserted-by":"publisher","first-page":"11541","DOI":"10.1128\/jvi.76.22.11541-11550.2002","volume":"76","author":"B Sainz Jr","year":"2002","unstructured":"Sainz, B. Jr. & Halford, W. P. Alpha\/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76(22), 11541\u201311550. https:\/\/doi.org\/10.1128\/jvi.76.22.11541-11550.2002 (2002).","journal-title":"J. Virol."},{"issue":"2","key":"98505_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1128\/jvi.01376-08","volume":"83","author":"E Bartee","year":"2009","unstructured":"Bartee, E., Mohamed, M. R., Lopez, M. C., Baker, H. V. & McFadden, G. The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts. J. Virol. 83(2), 498\u2013511. https:\/\/doi.org\/10.1128\/jvi.01376-08 (2009).","journal-title":"J. Virol."},{"key":"98505_CR14","doi-asserted-by":"publisher","unstructured":"Kerr, P. J. et al. Evolutionary history and Attenuation of Myxoma virus on two continents. PLoS Pathog. 8(10), e1002950. https:\/\/doi.org\/10.1371\/journal.ppat.1002950 (2012).","DOI":"10.1371\/journal.ppat.1002950"},{"key":"98505_CR15","doi-asserted-by":"publisher","unstructured":"Lee, A. J. & Ashkar, A. A. The dual nature of type I and type II interferons. Front. Immunol. 9, 2061. https:\/\/doi.org\/10.3389\/fimmu.2018.02061 (2018).","DOI":"10.3389\/fimmu.2018.02061"},{"issue":"5","key":"98505_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16(5), 448\u2013457. https:\/\/doi.org\/10.1038\/ni.3153 (2015).","journal-title":"Nat. Immunol."},{"issue":"1","key":"98505_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm0198-078","volume":"4","author":"J Liu","year":"1998","unstructured":"Liu, J. et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4(1), 78\u201383. https:\/\/doi.org\/10.1038\/nm0198-078 (1998).","journal-title":"Nat. Med."},{"issue":"6129","key":"98505_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro, J. R. et al. Persistent LCMV infection is controlled by Blockade of type I interferon signaling. Science 340(6129), 207\u2013211. https:\/\/doi.org\/10.1126\/science.1235214 (2013).","journal-title":"Science"},{"key":"98505_CR19","doi-asserted-by":"publisher","unstructured":"Ahlenstiel, G. et al. Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology. 141(4), 1231-9, 1239.e1-2, https:\/\/doi.org\/10.1053\/j.gastro.2011.06.069 (2011).","DOI":"10.1053\/j.gastro.2011.06.069"},{"issue":"4","key":"98505_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/hep.27092","volume":"60","author":"JM Werner","year":"2014","unstructured":"Werner, J. M. et al. Ribavirin improves the IFN-\u03b3 response of natural killer cells to IFN-based therapy of hepatitis C virus infection. Hepatology 60(4), 1160\u20131169. https:\/\/doi.org\/10.1002\/hep.27092 (2014).","journal-title":"Hepatology"},{"key":"98505_CR21","doi-asserted-by":"publisher","unstructured":"Pontiroli, F. et al. The timing of IFN\u03b2 production affects early innate responses to Listeria monocytogenes and determines the overall outcome of lethal infection. PLoS ONE. 7(8), e43455. https:\/\/doi.org\/10.1371\/journal.pone.0043455 (2012).","DOI":"10.1371\/journal.pone.0043455"},{"key":"98505_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139834","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.139834 (2020).","journal-title":"JCI Insight"},{"key":"98505_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd1554","author":"JS Lee","year":"2020","unstructured":"Lee, J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.abd1554 (2020).","journal-title":"Sci. Immunol."},{"issue":"5","key":"98505_CR24","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181(5), 1036\u20131045e9. https:\/\/doi.org\/10.1016\/j.cell.2020.04.026 (2020).","journal-title":"Cell"},{"key":"98505_CR25","doi-asserted-by":"publisher","unstructured":"Zhang, B. et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS ONE. 15(7), e0235458. https:\/\/doi.org\/10.1371\/journal.pone.0235458 (2020).","DOI":"10.1371\/journal.pone.0235458"},{"issue":"10","key":"98505_CR26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26(10), 1636\u20131643. https:\/\/doi.org\/10.1038\/s41591-020-1051-9 (2020).","journal-title":"Nat. Med."},{"issue":"1","key":"98505_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu, B., Huang, S. & Yin, L. The cytokine storm and COVID-19. J. Med. Virol. 93(1), 250\u2013256. https:\/\/doi.org\/10.1002\/jmv.26232 (2021).","journal-title":"J. Med. Virol."},{"key":"98505_CR28","doi-asserted-by":"publisher","unstructured":"Jose, R. J. & Manuel, A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir. Med. 8(6), e46\u2013e47. https:\/\/doi.org\/10.1016\/s2213-2600(20)30216-2 (2020).","DOI":"10.1016\/s2213-2600(20)30216-2"},{"issue":"15","key":"98505_CR29","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2020.17052","volume":"324","author":"M Kox","year":"2020","unstructured":"Kox, M., Waalders, N. J. B., Kooistra, E. J., Gerretsen, J. & Pickkers, P. Cytokine levels in critically ill patients with COVID-19 and other conditions. Jama 324(15), 1565\u20131567. https:\/\/doi.org\/10.1001\/jama.2020.17052 (2020).","journal-title":"Jama"},{"issue":"1","key":"98505_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","volume":"22","author":"IE Galani","year":"2021","unstructured":"Galani, I. E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat. Immunol. 22(1), 32\u201340. https:\/\/doi.org\/10.1038\/s41590-020-00840-x (2021).","journal-title":"Nat. Immunol."},{"key":"98505_CR31","doi-asserted-by":"publisher","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","volume":"127","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J. Clin. Virol. 127, 104370. https:\/\/doi.org\/10.1016\/j.jcv.2020.104370 (2020).","journal-title":"J. Clin. Virol."},{"key":"98505_CR32","doi-asserted-by":"publisher","first-page":"155190","DOI":"10.1016\/j.cyto.2020.155190","volume":"134","author":"M Mandel","year":"2020","unstructured":"Mandel, M., Harari, G., Gurevich, M. & Achiron, A. Cytokine prediction of mortality in COVID19 patients. Cytokine 134, 155190. https:\/\/doi.org\/10.1016\/j.cyto.2020.155190 (2020).","journal-title":"Cytokine"},{"issue":"10","key":"98505_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","volume":"22","author":"EM Conway","year":"2022","unstructured":"Conway, E. M. et al. Understanding COVID-19-associated coagulopathy. Nat. Rev. Immunol. 22(10), 639\u2013649. https:\/\/doi.org\/10.1038\/s41577-022-00762-9 (2022).","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"98505_CR34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm.3260","volume":"19","author":"G Schett","year":"2013","unstructured":"Schett, G., Elewaut, D., McInnes, I. B., Dayer, J. M. & Neurath, M. F. How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy. Nat. Med. 19(7), 822. https:\/\/doi.org\/10.1038\/nm.3260 (2013).","journal-title":"Nat. Med."},{"key":"98505_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11020241","author":"W Hafez","year":"2022","unstructured":"Hafez, W. et al. Treatment outcomes of tocilizumab in critically-Ill COVID-19 patients, single-centre retrospective study. Antibiot. (Basel). https:\/\/doi.org\/10.3390\/antibiotics11020241 (2022).","journal-title":"Antibiot. (Basel)"},{"key":"98505_CR36","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-835734\/v1","author":"BL Thoms","year":"2021","unstructured":"Thoms, B. L., Gosselin, J., Libman, B., Littenberg, B. & Budd, R. Efficacy of combination therapy with the JAK inhibitor baricitinib in the treatment of COVID-19. Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-835734\/v1 (2021).","journal-title":"Res. Sq"},{"issue":"6","key":"98505_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/s1074-7613(01)00151-0","volume":"14","author":"SM Hurst","year":"2001","unstructured":"Hurst, S. M. et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14(6), 705\u2013714. https:\/\/doi.org\/10.1016\/s1074-7613(01)00151-0 (2001).","journal-title":"Immunity"},{"key":"98505_CR38","doi-asserted-by":"publisher","unstructured":"Ranjbar, M., Rahimi, A., Baghernejadan, Z., Ghorbani, A. & Khorramdelazad, H. Role of CCL2\/CCR2 axis in the pathogenesis of COVID-19 and possible treatments: all options on the table. Int. Immunopharmacol. 113(Pt A), 109325. https:\/\/doi.org\/10.1016\/j.intimp.2022.109325 (2022).","DOI":"10.1016\/j.intimp.2022.109325"},{"key":"98505_CR39","doi-asserted-by":"publisher","first-page":"943563","DOI":"10.3389\/fimmu.2022.943563","volume":"13","author":"J Torres-Ruiz","year":"2022","unstructured":"Torres-Ruiz, J. et al. Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: results from a cohort study. Front. Immunol. 13, 943563. https:\/\/doi.org\/10.3389\/fimmu.2022.943563 (2022).","journal-title":"Front. Immunol."},{"issue":"6","key":"98505_CR40","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/jlb.3covbcr0621-300r","volume":"111","author":"AK Singh","year":"2022","unstructured":"Singh, A. K. et al. Opposing roles for sMAdCAM and IL-15 in COVID-19 associated cellular immune pathology. J. Leukoc. Biol. 111(6), 1287\u20131295. https:\/\/doi.org\/10.1002\/jlb.3covbcr0621-300r (2022).","journal-title":"J. Leukoc. Biol."},{"key":"98505_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9061292","author":"M Khan","year":"2021","unstructured":"Khan, M. et al. Gut dysbiosis and IL-21 response in patients with severe COVID-19. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms9061292 (2021).","journal-title":"Microorganisms"},{"issue":"51","key":"98505_CR42","doi-asserted-by":"publisher","first-page":"19771","DOI":"10.1074\/jbc.RA118.003668","volume":"293","author":"X Fu","year":"2018","unstructured":"Fu, X. et al. Enhanced interaction between sect.\u00a02 mutant and TCR V\u03b2 induces MHC II-independent activation of T cells via PKC\u03b8\/NF-\u03baB and IL-2R\/STAT5 signaling pathways. J. Biol. Chem. 293(51), 19771\u201319784. https:\/\/doi.org\/10.1074\/jbc.RA118.003668 (2018).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"98505_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41419-020-2636-4","volume":"11","author":"H Shi","year":"2020","unstructured":"Shi, H. et al. The Inhibition of IL-2\/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia. Cell. Death Dis. 11(6), 429. https:\/\/doi.org\/10.1038\/s41419-020-2636-4 (2020).","journal-title":"Cell. Death Dis."},{"key":"98505_CR44","doi-asserted-by":"publisher","unstructured":"Reyes, M. et al. Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19. bioRxiv. https:\/\/doi.org\/10.1101\/2020.09.02.280180 (2020).","DOI":"10.1101\/2020.09.02.280180"},{"issue":"1","key":"98505_CR45","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1038\/s41467-020-19706-9","volume":"11","author":"W Tian","year":"2020","unstructured":"Tian, W. et al. Immune suppression in the early stage of COVID-19 disease. Nat. Commun. 11(1), 5859. https:\/\/doi.org\/10.1038\/s41467-020-19706-9 (2020).","journal-title":"Nat. Commun."},{"issue":"1","key":"98505_CR46","doi-asserted-by":"publisher","first-page":"109793","DOI":"10.1016\/j.celrep.2021.109793","volume":"37","author":"N Liu","year":"2021","unstructured":"Liu, N. et al. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes. Cell. Rep. 37(1), 109793. https:\/\/doi.org\/10.1016\/j.celrep.2021.109793 (2021).","journal-title":"Cell. Rep."},{"issue":"2","key":"98505_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00045391-199408000-00002","volume":"1","author":"L Oleksowicz","year":"1994","unstructured":"Oleksowicz, L. & Dutcher, J. P. A review of the new cytokines: IL-4, IL-6, IL-11, and IL-12. Am. J. Ther. 1(2), 107\u2013115. https:\/\/doi.org\/10.1097\/00045391-199408000-00002 (1994).","journal-title":"Am. J. Ther."},{"key":"98505_CR48","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","volume":"23","author":"AN Theofilopoulos","year":"2005","unstructured":"Theofilopoulos, A. N., Baccala, R. & Beutler, B. Kono. Type I interferons (alpha\/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23, 307\u2013336. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115843 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"98505_CR49","doi-asserted-by":"publisher","unstructured":"Wang, Z., Pan, H. & Jiang, B. Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients. Signal. Transduct. Target. Ther. 5(1), 198. https:\/\/doi.org\/10.1038\/s41392-020-00306-4 (2020).","DOI":"10.1038\/s41392-020-00306-4"},{"issue":"3","key":"98505_CR50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0014-5793(92)80799-m","volume":"309","author":"AM Choi","year":"1992","unstructured":"Choi, A. M. & Jacoby, D. B. Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. FEBS Lett. 309(3), 327\u2013329. https:\/\/doi.org\/10.1016\/0014-5793(92)80799-m (1992).","journal-title":"FEBS Lett."},{"key":"98505_CR51","doi-asserted-by":"publisher","unstructured":"Fiedler, M. A. & Wernke-Dollries, K. and J. M. Stark. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 269(6 Pt 1), L865-72. https:\/\/doi.org\/10.1152\/ajplung.1995.269.6.L865 (1995).","DOI":"10.1152\/ajplung.1995.269.6.L865"},{"issue":"7","key":"98505_CR52","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1128\/jvi.71.7.5692-5695.1997","volume":"71","author":"T Murayama","year":"1997","unstructured":"Murayama, T. et al. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene. J. Virol. 71(7), 5692\u20135695. https:\/\/doi.org\/10.1128\/jvi.71.7.5692-5695.1997 (1997).","journal-title":"J. Virol."},{"issue":"2","key":"98505_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1006\/viro.1996.0374","volume":"221","author":"R Sheth","year":"1996","unstructured":"Sheth, R. et al. Rotavirus stimulates IL-8 secretion from cultured epithelial cells. Virology 221(2), 251\u2013259. https:\/\/doi.org\/10.1006\/viro.1996.0374 (1996).","journal-title":"Virology"},{"issue":"6359","key":"98505_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.aam9690","volume":"358","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. Visualizing the function and fate of neutrophils in sterile injury and repair. Science 358(6359), 111\u2013116. https:\/\/doi.org\/10.1126\/science.aam9690 (2017).","journal-title":"Science"},{"issue":"1","key":"98505_CR55","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41467-019-09046-8","volume":"10","author":"W Yang","year":"2019","unstructured":"Yang, W. et al. Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair. Nat. Commun. 10(1), 1076. https:\/\/doi.org\/10.1038\/s41467-019-09046-8 (2019).","journal-title":"Nat. Commun."},{"issue":"6","key":"98505_CR56","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.jaci.2021.03.047","volume":"147","author":"K Dorgham","year":"2021","unstructured":"Dorgham, K. et al. Distinct cytokine profiles associated with COVID-19 severity and mortality. J. Allergy Clin. Immunol. 147(6), 2098\u20132107. https:\/\/doi.org\/10.1016\/j.jaci.2021.03.047 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"98505_CR57","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2147\/ijgm.S412070","volume":"16","author":"A Iskandar","year":"2023","unstructured":"Iskandar, A. et al. Correlation between IL-8, C-reactive proteins (CRP) and neutrophil to lymphocyte ratio (NLR) as predictor of mortality in COVID-19 patients with diabetes mellitus comorbidity. Int. J. Gen. Med. 16, 2349\u20132354. https:\/\/doi.org\/10.2147\/ijgm.S412070 (2023).","journal-title":"Int. J. Gen. Med."},{"issue":"1","key":"98505_CR58","doi-asserted-by":"publisher","first-page":"12713","DOI":"10.1038\/s41598-024-63184-8","volume":"14","author":"K Uno","year":"2024","unstructured":"Uno, K. et al. Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts. Sci. Rep. 14(1), 12713. https:\/\/doi.org\/10.1038\/s41598-024-63184-8 (2024).","journal-title":"Sci. Rep."},{"key":"98505_CR59","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross, S. H. & Cantrell, D. A. Signaling and function of interleukin-2 in T lymphocytes. Annu. Rev. Immunol. 36, 411\u2013433. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053352 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"98505_CR60","doi-asserted-by":"publisher","first-page":"888897","DOI":"10.3389\/fimmu.2022.888897","volume":"13","author":"M Eskandarian Boroujeni","year":"2022","unstructured":"Eskandarian Boroujeni, M. et al. Dysregulated interferon response and immune hyperactivation in severe COVID-19: targeting stats as a novel therapeutic strategy. Front. Immunol. 13, 888897. https:\/\/doi.org\/10.3389\/fimmu.2022.888897 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"98505_CR61","doi-asserted-by":"publisher","first-page":"7254","DOI":"10.1038\/s41467-022-34895-1","volume":"13","author":"N Smith","year":"2022","unstructured":"Smith, N. et al. Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity. Nat. Commun. 13(1), 7254. https:\/\/doi.org\/10.1038\/s41467-022-34895-1 (2022).","journal-title":"Nat. Commun."},{"issue":"5","key":"98505_CR62","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.4049\/jimmunol.1100926","volume":"187","author":"A Novikov","year":"2011","unstructured":"Novikov, A. et al. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1\u03b2 production in human macrophages. J. Immunol. 187(5), 2540\u20132547. https:\/\/doi.org\/10.4049\/jimmunol.1100926 (2011).","journal-title":"J. Immunol."},{"issue":"7","key":"98505_CR63","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","volume":"184","author":"KD Mayer-Barber","year":"2010","unstructured":"Mayer-Barber, K. D. et al. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184(7), 3326\u20133330. https:\/\/doi.org\/10.4049\/jimmunol.0904189 (2010).","journal-title":"J. Immunol."},{"issue":"7507","key":"98505_CR64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511(7507), 99\u2013103. https:\/\/doi.org\/10.1038\/nature13489 (2014).","journal-title":"Nature"},{"key":"98505_CR65","doi-asserted-by":"publisher","unstructured":"Ichikawa, T. et al. Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells. Biochem. Biophys. Res. Commun. 294(2), 414\u2013422 https:\/\/doi.org\/10.1016\/s0006-291x(02)00502-8 (2002).","DOI":"10.1016\/s0006-291x(02)00502-8"},{"key":"98505_CR66","unstructured":"World Health Organization. Clinical management of COVID-19: Living guideline. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2023.1 (Accessed 13 Jan 2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98505-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98505-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98505-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:13:05Z","timestamp":1745431985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98505-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98505"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98505-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14209"}}